ARDX•benzinga•
Ardelyx Presents Additional Data On IBSRELA, A First-In-Class Treatment For IBS-C In Adults At The 2024 Digestive Disease Week Conference
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 21, 2024 by benzinga